DAMORA THERAPEUTICS INC (DMRA)
NASDAQHealth CareBiotechnologySnapshot 2026-07-07
$30.00+0.67%
Close 2026-07-07 · 1-day change
Reading DMRA? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track DMRA free→NASDAQHealth CareBiotechnologySnapshot 2026-07-07
Reading DMRA? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track DMRA free→QuarterlyIQ Insights · DMRA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | |
|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||
| R&D Expenses | 50.0 | 26.9 | 6.4 | 23.8 | 48.2 | 38.5 | 24.6 |
| Operating Income | (239.1) | (210.9) | (22.3) | (39.9) | (61.2) | (52.2) | (33.6) |
| Earnings from Continuing Operations | |||||||
| Other Non-Operating Income / Expenses | 4.1 | 1.1 | 0.9 | 1.6 | (0.4) | 0.5 | (1.2) |
| EBT, Incl. Unusual Items | (235.0) | (209.8) | (21.4) | (38.3) | (61.6) | (51.8) | (34.8) |
| Income Tax Expense | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||
| Net Income | (235.1) | (209.8) | (21.4) | (38.3) | (61.6) | (51.8) | (34.8) |
| Per Share | |||||||
| Basic EPS | (6.85) | 3.98 | (18.53) | (36.08) | (2.43) | — | — |
| Diluted EPS | (6.85) | 3.98 | (18.53) | (36.08) | (2.43) | — | — |
| Dividend per Share | — | 0.00 | — | — | 0.00 | 0.00 | 0.00 |
| Basic Weighted Avg Shares | 34.3 | 1.4 | 1.2 | 1.1 | 25.4 | — | — |
| Diluted Weighted Avg Shares | 34.3 | 1.4 | 1.2 | 1.1 | 25.4 | — | — |
| Supplemental | |||||||
| EBIT | (239.1) | (210.9) | (22.3) | (39.9) | (61.2) | (52.2) | (33.6) |
| Effective Tax Rate | -0.0% | -0.0% | -0.2% | 0.0% | 0.0% | 0.0% | 0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.